Ocular Therapeutix Inc. buy BiotechBee
Start price
07.09.22
/
60%
€5.70
Target price
31.12.24
€10.00
Performance (%)
43.52%
End price
14.12.24
€8.18
Summary
This prediction ended on 14.12.24 with a price of €8.18. With a performance of 43.52% the BUY prediction by BiotechBee was a big success. BiotechBee has 60% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Ocular Therapeutix Inc. | -6.880% | -6.880% | 12.790% | 142.359% |
| iShares Core DAX® | 1.644% | 4.865% | 25.089% | 64.694% |
| iShares Nasdaq 100 | 0.747% | 2.923% | 8.975% | 109.729% |
| iShares Nikkei 225® | 2.442% | 6.212% | 21.408% | 55.832% |
| iShares S&P 500 | 0.618% | 2.843% | 5.726% | 67.674% |
According to BiotechBee what are the pros and cons of Ocular Therapeutix Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Ocular Therapeutix Inc. diskutieren
Buy mit Kursziel 10,0
In the thread Trading Ocular Therapeutix Inc.
Buy beendet

